查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1666181

全球健康監測系統市場 - 2025 至 2033 年

Global Health Monitoring System Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球健康監測系統市場規模達到 512.6 億美元，預計到 2033 年將達到 994.9 億美元，2025-2033 年預測期間的複合年成長率為 7.5%。

健康監測系統是一種使用醫療設備、感測器和穿戴式技術監測個人生理參數、生命徵象和整體健康狀況的技術。它可用於醫院環境、家庭護理或遠程，實現即時資料收集、及早發現健康異常並及時進行醫療干預。健康監測系統對於慢性病管理、遠距患者監測和預防性醫療保健至關重要，可以改善患者的治療效果並減輕醫療機構的負擔。

市場動態：

促進因素與約束因素

科技進步的崛起

技術進步正在推動全球健康監測系統市場的成長。穿戴式裝置、遠端病人監控、人工智慧和物聯網整合以及智慧感測器正在改變健康資料的收集、分析和利用。這些進步使得即時監測生命徵象、早期發現異常以及改善慢性病管理成為可能。基於雲端的平台促進了無縫資料儲存和共享，增強了醫療保健提供者的決策能力。這提高了健康監測系統的準確性、效率和可近性，推動了全球市場的擴張。

例如，2024 年 8 月，海得拉巴推出了世界上第一個由 Bisam Pharmaceuticals 開發的人工智慧醫療監測應用程式「Quick Vitals」。這款人工智慧應用程式提供即時健康監測、個人化見解和預測分析。它旨在與穿戴式裝置配合使用，透過提高診斷準確性和主動護理，有望徹底改變患者護理。

資料隱私和安全問題

由於數位健康解決方案和遠端監控設備的日益普及，全球健康監測系統市場面臨著資料隱私和安全方面的挑戰。網路安全威脅、未經授權的存取和資料外洩對病患的保密和信任構成重大風險。 GDPR 和 HIPAA 等健康資料保護法規的合規性使市場變得複雜，阻礙了資料保護基礎設施不夠健全的地區廣泛採用，從而限制了市場成長。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 科技進步的崛起
    • 限制
      • 資料隱私和安全問題
    • 機會
    • 影響分析

第5章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章：依產品類型

  • 血糖監測系統
  • 心臟監測設備
  • 多參數監測設備
  • 呼吸監測設備
  • 血流動力學/壓力監測設備
  • 體重監測設備
  • 其他

第 7 章：按指徵

  • 糖尿病
  • 心臟病學
  • 呼吸系統
  • 體重管理
  • 其他

第 8 章：按連結性

  • 無線健康監測設備
  • 有線健康監測設備

第 9 章：按最終用戶

  • 醫院和診所
  • 門診手術中心 (ASC)
  • 家庭護理設置
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • Medtronic Plc
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Koninklijke Philips NV
  • Abbott Laboratories
  • GE Healthcare
  • Omron Healthcare, Inc
  • Nihon Kohden Corporation
  • Masimo Corporation
  • Biotronik, Inc
  • Siemens Healthineers AG
  • Boston Scientific Corporation
  • Similar data will be provided for each market player.
  • 歐拉健康
    • 管道產品描述
    • 產品關鍵績效指標 (KPI)
    • 主要活動
    • 市場進入時間表
    • 產品滲透率
    • 銷售估計和預測
  • 超人
  • 生物福米斯
  • Withings
  • 將為每個市場參與者提供類似的資料。

第 13 章：附錄

簡介目錄
Product Code: MD9191

The Global Health Monitoring System Market reached US$ 51.26 Billion in 2024 and is expected to reach US$ 99.49 Billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.

A Health Monitoring System is a technology that monitors an individual's physiological parameters, vital signs, and overall health status using medical devices, sensors, and wearable technologies. It can be used in hospital settings, home care, or remotely, enabling real-time data collection, early detection of health abnormalities, and timely medical intervention. Health Monitoring Systems are crucial for chronic disease management, remote patient monitoring, and preventive healthcare, enhancing patient outcomes and reducing healthcare facility burden.

Market Dynamics: Drivers & Restraints

Rise in Technological Advancements

Technological advancements are driving the growth of the Global Health Monitoring System Market. Wearable devices, remote patient monitoring, AI and IoT integration, and smart sensors are transforming health data collection, analysis, and utilization. These advancements enable real-time monitoring of vital signs, early detection of abnormalities, and improved management of chronic conditions. Cloud-based platforms facilitate seamless data storage and sharing, enhancing healthcare providers' decision-making. This has increased the accuracy, efficiency, and accessibility of health monitoring systems, driving market expansion globally.

For instance, in August 2024, Hyderabad has launched the world's first AI-powered healthcare monitoring app, 'Quick Vitals', by Bisam Pharmaceuticals. This AI-powered app offers real-time health monitoring, personalized insights, and predictive analytics. It's designed to work with wearable devices, potentially revolutionizing patient care with improved diagnostic accuracy and proactive care.

Data Privacy and Security Concerns

The Global Health Monitoring System Market faces challenges in data privacy and security due to the increasing adoption of digital health solutions and remote monitoring devices. Cybersecurity threats, unauthorized access, and data breaches pose significant risks to patient confidentiality and trust. Regulatory compliance with health data protection laws like GDPR and HIPAA complicates the market, hindering widespread adoption in regions with less robust data protection infrastructure, limiting market growth.

Segment Analysis

The global health monitoring system market is segmented based on Product Type, Indication, Connectivity, End User and Region.

Product Type:

Blood Glucose Monitoring Systems segment is expected to dominate the Health Monitoring System market share

The blood glucose monitoring systems segment holds a major portion of the health monitoring system market share and is expected to continue to hold a significant portion of the health monitoring system market share during the forecast period.

Blood glucose monitoring systems are crucial in managing diabetes, a condition affecting Billions worldwide. These systems enable real-time monitoring of blood sugar levels, enabling individuals to track fluctuations and adjust lifestyles or medication. Continuous glucose monitoring devices and non-invasive solutions have revolutionized diabetes management, providing accurate readings without frequent finger pricks.

For instance, in November 2024, Beurer India has launched the GL 22 Blood Glucose Monitor, a health monitoring solution designed for the Indian market. The device, manufactured under Beurer's "Make in India" initiative, combines German precision with advanced technology to meet local needs. It offers comprehensive monitoring capabilities, including average readings for 7, 14, 30, and 90 days, providing insights into blood glucose trends. These features align with HbA1c levels, a crucial marker for long-term blood sugar control, enabling users and healthcare providers to manage diabetes more effectively.

Furthermore, in June 2024, Prevounce Health has launched its first remote blood glucose monitoring device, the Pylo GL1-LTE. This clinically validated device connects to multiple cellular networks for reliable data transmission throughout the United States. It is compatible with the Prevounce remote care management platform and can integrate with other health software via the Pylo cloud API.

Moreover, technological advancements, like smart glucometers integrated with mobile applications, improve treatment outcomes and encourage preventive care. As diabetes prevalence increases globally, the demand for blood glucose monitoring systems continues to drive market growth.

End User:-

Hospitals & Clinics segment is the fastest-growing segment in Health Monitoring System market share

The hospitals & clinics segment is the fastest-growing segment in the Health Monitoring System market share and is expected to hold the market share over the forecast period.

Hospitals and clinics are a crucial segment in the Global Health Monitoring System Market, relying on advanced devices for accurate patient assessment and timely medical interventions. These systems, including vital sign monitors, cardiac monitors, and remote patient monitoring solutions, help healthcare professionals track patients' health status in real-time, particularly in critical care units and emergency settings. The integration of electronic health records with monitoring devices enhances clinical decision-making and patient care efficiency. With rising patient admissions due to chronic diseases and aging populations, hospitals and clinics remain vital in the market.

Geographical Analysis

North America is expected to hold a significant position in the Health Monitoring System market share

North America holds a substantial position in the Health Monitoring System market and is expected to hold most of the market share due to its advanced healthcare infrastructure, high healthcare expenditure, and the adoption of advanced technologies. The region is home to major health tech companies and is a hub for innovation in digital health solutions like wearable devices and remote monitoring systems. The increasing prevalence of chronic diseases like diabetes and cardiovascular conditions has increased the demand for continuous health monitoring systems. Government initiatives and strong health data privacy regulations ensure system security and reliability.

For instance, in February 2024, Particle Health, a healthcare platform, has launched its Patient Monitoring Solution, offering a 360-degree view of patients' care journeys and interactions with the healthcare system. The solution aims to shift from reactive to proactive care by providing advanced data insights on patient resource utilization. This data aids in more accurate risk management in Value Based Care models, advancing care delivery, and improving patient outcomes.

Europe is growing at the fastest pace in the Health Monitoring System market

Europe holds the fastest pace in the Health Monitoring System market and is expected to hold most of the market share due to its focus on improving healthcare outcomes through innovative technologies. The increasing adoption of telemedicine, remote patient monitoring, and connected devices has improved healthcare delivery, particularly in rural areas. The high prevalence of lifestyle diseases and aging population necessitate efficient health monitoring solutions. Strong government support, eHealth strategies, and robust regulatory frameworks, including GDPR, promote the integration of advanced monitoring systems across public and private healthcare institutions.

For instance, in September 2024, Control Station has launched System Health Monitoring (SHM), a tiered service offering that uses PlantESP Loop Performance Monitoring solution's intelligence for proactive monitoring of deployments. The service enables rapid response to resource issues and provides guidance for achieving world-class control, enrolling dozens of PlantESP licensees and production facilities.

Competitive Landscape

The major global players in the Health Monitoring System market include Medtronic Plc, Koninklijke Philips N.V., Abbott Laboratories, GE Healthcare, Omron Healthcare, Inc, Nihon Kohden Corporation, Masimo Corporation, Biotronik, Inc, Siemens Healthineers AG, Boston Scientific Corporation and among others.

Key Developments

  • In January 2025, AIIMS Raebareli and AIIMS Delhi have launched a real-time health monitoring system at the Maha Kumbh Mela 2025, in collaboration with healthtech firm Lifesigns. The system collects and analyzes vital health data such as ECG, heart rate, respiration, SpO2, blood pressure, and posture, aiming to improve medical response and patient care during the massive gathering.
  • In May 2024, LG Electronics has launched Primefocus Health, a healthcare-delivery platform that uses technologies and therapies for remote patient monitoring and access to new therapies. The platform will allow providers to collect patient data, communicate with patients, track progress, and intervene when needed. It will integrate with electronic health record systems and use AI and machine learning capabilities. This is the first platform launched by LG Electronics North America Innovation Center and LG NOVA.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Health Monitoring System market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Product Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Indication
  • 3.3. Snippet by Connectivity
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Data Privacy and Security Concerns
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Blood Glucose Monitoring Systems *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Cardiac Monitoring Devices
  • 6.4. Multi-Parameter Monitoring Devices
  • 6.5. Respiratory Monitoring Devices
  • 6.6. Hemodynamic/Pressure Monitoring Devices
  • 6.7. Weight Monitoring Devices
  • 6.8. Others

7. By Indication

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 7.1.2. Market Attractiveness Index, By Indication
  • 7.2. Diabetes*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiology
  • 7.4. Respiratory
  • 7.5. Weight Management
  • 7.6. Others

8. By Connectivity

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 8.1.2. Market Attractiveness Index, By Connectivity
  • 8.2. Wireless Health Monitoring Devices*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Wired Health Monitoring Devices

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals & Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers (ASCs)
  • 9.4. Homecare Settings
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

  • 12.1. Medtronic Plc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Koninklijke Philips N.V.
  • 12.3. Abbott Laboratories
  • 12.4. GE Healthcare
  • 12.5. Omron Healthcare, Inc
  • 12.6. Nihon Kohden Corporation
  • 12.7. Masimo Corporation
  • 12.8. Biotronik, Inc
  • 12.9. Siemens Healthineers AG
  • 12.10. Boston Scientific Corporation
  • Similar data will be provided for each market player.

Emerging Market Players

  • 12.11. Oura Health*
    • 12.11.1. Pipeline Products Description
    • 12.11.2. Product Key Performance Indicators (KPIs)
    • 12.11.3. Key Activities
    • 12.11.4. Market Entry Timelines
    • 12.11.5. Product Penetration Rate
    • 12.11.6. Sales Estimation and Projections
  • 12.12. Ultrahuman
  • 12.13. Biofourmis
  • 12.14. Withings
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us